Influence of Early-feeding on Digestive Function of Patients After Esophageal Recontraction Surgery
NCT ID: NCT05892263
Last Updated: 2023-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2022-11-01
2025-07-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At present, there is no research on the effect of early force-feeding on gastrointestinal motility. Therefore, this study aims to explore whether early gastrointestinal force-feeding can not only reduce the infection rate and systemic inflammation, but also promote gastrointestinal motility. Without using drugs, Reduce drug side effects and abdominal discomfort, advance the time of gastrointestinal force-feeding, reduce complications of postoperative lung and wound anastomosis leakage, complete postoperative care for esophageal cancer, and reduce postoperative mortality.
At present, there is no research on the effect of early force-feeding on gastrointestinal motility. Therefore, this study aims to explore whether early gastrointestinal force-feeding can not only reduce the infection rate and systemic inflammation, but also promote gastrointestinal motility. Without using drugs, Reduce drug side effects and abdominal discomfort, advance the time of gastrointestinal force-feeding, reduce complications of postoperative lung and wound anastomosis leakage, complete postoperative care for esophageal cancer, and reduce postoperative mortality.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resumption of Enteral Feeding After Bowel Anastomosis
NCT06906289
Conventional Oral Intake vs Delayed Oral Intake With Jejunostomy Feeding After Esophagectomy (JNS Study)
NCT05318404
Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery
NCT04266015
Early Oral Feeding for Patients After Pancreaticoduodenectomy
NCT05573399
Oral Anti-Infective Agent for Esophageal Anastomotic Leakage
NCT00942526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Esophageal cancer surgery is quite complicated, including esophagectomy, radical lymphadenectomy, esophagus and gastric tube re-anastomosis, etc. The difficulty of surgery is related to its high morbidity and mortality. According to the literature review, the overall incidence rate is 59%, and death occurs within 30 days The postoperative complication rate of esophageal cancer is 5%, and the 90-day mortality rate is 13%. Therefore, the treatment of postoperative complications of esophageal cancer is the focus of postoperative care; postoperative complications: shock, pneumonia, anastomotic leakage, delayed gastric emptying, intestinal obstruction, arrhythmia , chylothorax, diaphragmatic hernia, pulmonary embolism, these complications will increase the risk of postoperative death, among which the occurrence of pneumonia leads to a significant increase in mortality and anastomotic leakage as high as 50%.
Radiation therapy before esophagectomy will lead to pulmonary fibrosis, and one-lung ventilation will be used during the operation to increase the surgical field of view for esophageal reconstruction. These two factors lead to a postoperative pulmonary infection rate of 67% in these patients. Unavoidable involvement or sacrifice of the vagus nerve during surgery leads to postoperative complications related to poor digestive function, such as slow gastrointestinal emptying, gastroesophageal reflux, and intestinal obstruction, as high as 39%. The risk of severe pneumonia is a dangerous complication after esophageal surgery; in addition, the esophageal and gastric reconstruction is poorly healed due to gastric juice erosion, resulting in leakage, resulting in systemic sepsis infection and the need for reoperation. It can be seen that gastrointestinal motility after esophageal cancer surgery is related to two common and fatal complications after surgery, which is what needs to be paid more attention to after surgery. If the gastrointestinal function recovers well after surgery, it can be expected to reduce postoperative complications and increase Adequate caloric intake after surgery and accelerated postoperative recovery.
After esophagectomy and reconstruction, intestinal ischemia or intestinal paralysis, lack of intestinal stimulation and oral nutrition can aggravate atrophy and impair the permeability of intestinal mucosa, which not only makes it easy for intestinal bacteria and endotoxin to migrate and enter the blood, At present, early intestinal feeding has been proved to protect the integrity of the intestinal mucosa and improve the postoperative systemic inflammatory response and infection rate of patients, especially pneumonia. Relying on parenteral nutrition, coupled with postoperative exhaust gas or defecation with drugs, can be force-fed. In addition to the side effects of gastrointestinal discomfort (nausea, diarrhea, abdominal pain), parenteral nutrition is likely to cause blood sugar instability and liver index. Abnormal and even increased infection rate, gastrointestinal force feeding was delayed for 36-48 hours before starting.
At present, there is no research on the effect of early force-feeding on gastrointestinal motility. Therefore, this study aims to explore whether early gastrointestinal force-feeding can not only reduce the infection rate and systemic inflammation, but also promote gastrointestinal motility. Without using drugs, Reduce drug side effects and abdominal discomfort, advance the time of gastrointestinal force-feeding, reduce complications of postoperative lung and wound anastomosis leakage, complete postoperative care for esophageal cancer, and reduce postoperative mortality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early intestinal force-feeding and drugs to promote gastrointestinal motility
early feeding
Enteral force feeding with 5% dextrose injection within 24 hours after operation
early enteral feeding
early feeding
Enteral force feeding with 5% dextrose injection within 24 hours after operation
giving force-feeding after gas or defecation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
early feeding
Enteral force feeding with 5% dextrose injection within 24 hours after operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Esophagectomy & reconstruction
* Esophagotomy
* Esophageal reconstruction-with gastric tube
* Esophageal reconstruction-with colon
* Esophageal reconstruction with small intestine
Exclusion Criteria
* Postoperative hemorrhage
* Intestinal obstruction
* Shock
20 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202205077MIND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.